Evidence map›Paper›PMID 35336210›Full record

ArticleMicroorganisms2022

CRISPR-Cas9 Mediated Knockout of

Armi M Chaudhari, Sachin Vyas, Vijai Singh, Amrutlal Patel, Chaitanya Joshi, Madhvi N Joshi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Armi M ChaudhariGujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, MS Building, 6th Floor, Sector 11, Gandhinagar 382011, Gujarat, India.ORCID 0000-0001-7908-2157
Sachin VyasGujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, MS Building, 6th Floor, Sector 11, Gandhinagar 382011, Gujarat, India.ORCID 0000-0001-9732-4172
Vijai SinghDepartment of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana 382715, Gujarat, India.
Amrutlal PatelGujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, MS Building, 6th Floor, Sector 11, Gandhinagar 382011, Gujarat, India.
Chaitanya JoshiGujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, MS Building, 6th Floor, Sector 11, Gandhinagar 382011, Gujarat, India.
Madhvi N JoshiGujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, MS Building, 6th Floor, Sector 11, Gandhinagar 382011, Gujarat, India.
Government of Gujarat · INIndrashil University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptokinase is an enzyme that can break down the blood clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism. Demand for streptokinase is higher globally than production due to increased incidences of various heart conditions. The main source of streptokinase is various strains of

Indexed as

CRISPR-Cas9FasXknockoutSagDstreptokinasetherapy

Identifiers

PMID35336210
PMCPMC8953821
OpenAlexW4220859025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.